OBJECTIVE: To determine the contribution of triggering receptor expressed on myeloid cells (TREM)-1 in acute pancreatitis (AP). DESIGN: Prospective study. SETTING: General intensive care unit at Kobe University Hospital. PATIENTS: Forty-eight patients with AP and seven patients as control. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We measured serum concentrations of soluble TREM-1 (sTREM-1) at the time of admission by enzyme-linked immunoadsorbent assay. Serum sTREM-1 levels increased significantly in AP (63 +/- 11 pg/mL) and correlated with Ranson score (R = .628, p < .001) and Acute Physiology and Chronic Health Evaluation II score (R = .504, p < .001). Serum TREM-1 levels were higher in patients with early organ dysfunction (which occurred within 7 days after onset) than those without early organ dysfunction (101 +/- 19 vs. 25 +/- 4 pg/mL, p < .001). Incidences of early organ dysfunction in patients whose serum sTREM-1 levels were < or = 40 and > 40 pg/mL were 17% and 83%, respectively (p < .001). The usefulness of serum sTREM-1 in detecting early organ dysfunction was superior to that of C-reactive protein, interleukin-6, interleukin-8, Ranson score, and Acute Physiology and Chronic Health Evaluation II score. Serum sTREM-1 levels decreased with resolution of early organ dysfunction. CONCLUSIONS: Serum sTREM-1 levels were significantly increased and correlated with disease severity and early organ dysfunction in patients with AP. Serum sTREM-1 level may be a useful marker for early organ dysfunction in AP.
OBJECTIVE: To determine the contribution of triggering receptor expressed on myeloid cells (TREM)-1 in acute pancreatitis (AP). DESIGN: Prospective study. SETTING: General intensive care unit at Kobe University Hospital. PATIENTS: Forty-eight patients with AP and seven patients as control. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We measured serum concentrations of soluble TREM-1 (sTREM-1) at the time of admission by enzyme-linked immunoadsorbent assay. Serum sTREM-1 levels increased significantly in AP (63 +/- 11 pg/mL) and correlated with Ranson score (R = .628, p < .001) and Acute Physiology and Chronic Health Evaluation II score (R = .504, p < .001). Serum TREM-1 levels were higher in patients with early organ dysfunction (which occurred within 7 days after onset) than those without early organ dysfunction (101 +/- 19 vs. 25 +/- 4 pg/mL, p < .001). Incidences of early organ dysfunction in patients whose serum sTREM-1 levels were < or = 40 and > 40 pg/mL were 17% and 83%, respectively (p < .001). The usefulness of serum sTREM-1 in detecting early organ dysfunction was superior to that of C-reactive protein, interleukin-6, interleukin-8, Ranson score, and Acute Physiology and Chronic Health Evaluation II score. Serum sTREM-1 levels decreased with resolution of early organ dysfunction. CONCLUSIONS: Serum sTREM-1 levels were significantly increased and correlated with disease severity and early organ dysfunction in patients with AP. Serum sTREM-1 level may be a useful marker for early organ dysfunction in AP.
Authors: Qingkun Liu; Emily M Johnson; Rachel K Lam; Qian Wang; Hong Bo Ye; Edward N Wilson; Paras S Minhas; Ling Liu; Michelle S Swarovski; Stephanie Tran; Jing Wang; Swapnil S Mehta; Xi Yang; Joshua D Rabinowitz; Samuel S Yang; Mehrdad Shamloo; Christoph Mueller; Michelle L James; Katrin I Andreasson Journal: Nat Immunol Date: 2019-07-01 Impact factor: 25.606
Authors: Zheng Lu; Yan Liu; Yuan-hang Dong; Xian-bao Zhan; Yi-qi Du; Jun Gao; Yan-fang Gong; Zhao-shen Li Journal: Intensive Care Med Date: 2011-10-27 Impact factor: 17.440
Authors: Jae Jun Park; Jae Hee Cheon; Bo Young Kim; Duk Hwan Kim; Eun Soo Kim; Tae Il Kim; Kyoung Ryul Lee; Won Ho Kim Journal: Dig Dis Sci Date: 2008-10-31 Impact factor: 3.199
Authors: Guy J Oudhuis; Judith Beuving; Dennis Bergmans; Ellen E Stobberingh; Guul ten Velde; Catharina F Linssen; Annelies Verbon Journal: Intensive Care Med Date: 2009-04-03 Impact factor: 17.440